These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38246725)

  • 1. Farrerol suppresses osteoclast differentiation and postmenopausal osteoporosis by inhibiting the nuclear factor kappa B signaling pathway.
    Lu W; Qi G; Yang X; Li D; Chen W; Zeng Q; Jiang Z
    J Pharmacol Sci; 2024 Feb; 154(2):113-126. PubMed ID: 38246725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
    Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
    J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitavastatin prevents ovariectomy-induced osteoporosis by regulating osteoclastic resorption and osteoblastic formation.
    Cheon YH; Lee CH; Kim S; Park GD; Kwak SC; Cho HJ; Kim JY; Lee MS
    Biomed Pharmacother; 2021 Jul; 139():111697. PubMed ID: 34243614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways.
    Chen K; Yan Z; Wang Y; Yang Y; Cai M; Huang C; Li B; Yang M; Zhou X; Wei X; Yang C; Chen Z; Zhai X; Li M
    Biomed Pharmacother; 2020 Jun; 126():110067. PubMed ID: 32272431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways.
    Yang F; Su Y; Liang J; Wang K; Lian H; Chen J; Xu J; Zhao J; Liu Q
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37052260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
    Yang T; Chen W; Gan K; Wang C; Xie X; Su Y; Lian H; Xu J; Zhao J; Liu Q
    J Transl Med; 2023 Nov; 21(1):839. PubMed ID: 37993937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
    Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
    Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.
    Yuan SG; Hu HL; Wang XJ; Yang JC; Zhou RP; Bai XC; Lai PL
    Orthop Surg; 2022 Jun; 14(6):1203-1216. PubMed ID: 35470579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosavin suppresses osteoclastogenesis
    Zhang W; Zhang W; Huo L; Chai Y; Liu Z; Ren Z; Yu C
    Ann Transl Med; 2021 Mar; 9(5):383. PubMed ID: 33842604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-κB, ERK, and JNK signaling pathways.
    Yin Z; Zhu W; Wu Q; Zhang Q; Guo S; Liu T; Li S; Chen X; Peng D; Ouyang Z
    Eur J Pharmacol; 2019 Sep; 859():172550. PubMed ID: 31323222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
    Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
    Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
    Chen X; Zhi X; Pan P; Cui J; Cao L; Weng W; Zhou Q; Wang L; Zhai X; Zhao Q; Hu H; Huang B; Su J
    FASEB J; 2017 Nov; 31(11):4855-4865. PubMed ID: 28739641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
    Zhu M; Liu H; Sun K; Liu J; Mou Y; Qi D; Zhou C; Abudunaibi M; Tasiken B; Li J; Cheng H; Huang H
    Biomed Pharmacother; 2020 Mar; 123():109769. PubMed ID: 31846839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anethole inhibits RANKL-induced osteoclastogenesis by downregulating ERK/AKT signaling and prevents ovariectomy-induced bone loss in vivo.
    Qu H; Zhang Y; He R; Lin N; Wang C
    Int Immunopharmacol; 2021 Nov; 100():108113. PubMed ID: 34530203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
    Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
    J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo.
    Baek JM; Kim JY; Yoon KH; Oh J; Lee MS
    Int J Biol Sci; 2016; 12(5):478-88. PubMed ID: 27019631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
    Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
    J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Senkyunolide H attenuates osteoclastogenesis and postmenopausal osteoporosis by regulating the NF-κB, JNK and ERK signaling pathways.
    Yang D; Liu T; Jiang G; Hu X; Zheng T; Li T; Gao Z; Ouyang Z; Zhu B
    Biochem Biophys Res Commun; 2020 Dec; 533(3):510-518. PubMed ID: 32977943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.